Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1562-1566

  Monleau, Marjorie ^a   Butel, Christelle ^a   Delaporte, Eric ^a   Boillot, Francois ^b,c   Peeters, Martine ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b Alter Santé Internationale and Développement   (France)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

903 filter paper; DBS; DPS; Dried spot conservation; Drug resistance surveillance; Resource limited countries; RNA stability; Viral load

Indexed keywords

BLOOD EXTRACT; DEOXYRIBONUCLEASE; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; VIRUS LOAD; ANTIVIRAL RESISTANCE; BLOOD; DESICCATION; GENETICS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MICROBIAL SENSITIVITY TEST; PLASMA; POLYMERASE CHAIN REACTION; PROCEDURES; TEMPERATURE; TIME; VIROLOGY;

BLOOD; DESICCATION; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMA; POLYMERASE CHAIN REACTION; RNA, VIRAL; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 77954755249     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq205     Document Type: Article

References (18)

1. Buckton AJ. New methods for the surveillance of HIV drug resistance in the resource poor world. Curr Opin Infect Dis 2008; 21: 653-8.
2. Hamers RL, Smit PW, Stevens W et al. Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 2009; 14: 619-29.
3. Johannessen A. Quantification of HIV-1 RNA on dried blood spots. AIDS 2010; 24: 475-6.
4. Monleau M, Montavon C, Laurent C et al. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for HIV-1 RNA quantification and PCR amplification for drug resistance testing. J Clin Microbiol 2009; 47: 1107-18.
5. Garcia-Lerma JG, McNulty A, Jennings C et al. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37°C and high humidity. J Antimicrob Chemother 2009; 64:33-6.
6. Marconi A, Balestrieri M, Comastri G et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009; 15:93-7.
7. Garrido C, Zahonero N, Corral A et al. Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests. J Clin Microbiol 2009; 47: 1031-6.
8. Rouet F, Chaix ML, Nerrienet E et al. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr 2007; 45: 380-8.
9. Johannessen A, Garrido C, Zahonero N et al. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin Infect Dis 2009; 49: 976-81.
10. Nelson JA, Loftis AM, Kamwendo D et al. Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature. J Clin Microbiol 2009; 47: 1209-11.
11. van Deursen P, Oosterlaken T, Andre P et al. Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0. J Clin Virol 2010; 47: 120-5.
12. Ziemniak C, George-Agwu A, Moss WJ et al. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J Virol Methods 2006; 136: 238-47.
13. Masciotra S, Garrido C, Youngpairoj AS et al. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 2007; 21: 2503-11.
14. McNulty A, Jennings C, Bennett D et al. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol 2007; 45: 517-21.
15. Hallack R, Doherty LE, Wethers JA et al. Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene® HIV-1 genotyping assay. J Clin Virol 2008; 41: 283-7.
16. Hearps AC, Ryan CE, Morris LM et al. Stability of dried blood spots for HIV-1 drug resistance analysis. Curr HIV Res 2010; 8: 134-40.
17. Buckton AJ, Bissett SL, Myers RE et al. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J Antimicrob Chemother 2008; 62: 1191-8.
18. Steegen K, Luchters S, Demecheleer E et al. Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots. J Clin Microbiol 2007; 45: 3342-51.